Efavirenz
At a glance
- Drug Originator Merck & Co
- Drug Licenced by Banyu; Bristol-Myers Squibb; Merck Sharp & Dohme
- Drug Class Alkynes; Antiretrovirals; Benzoxazines; Cyclopropanes; Small molecules
- Mechanism of Action Non-nucleoside reverse transcriptase inhibitors
- USA Patent Applicants BRISTOL MYERS SQUIBB
- USA Patents 8
- NDAs 2
- Patent Applications 4,684
Table of Contents
Disclaimer